Blood · 2010 · 84 citations · 2 references
Life SciencesImmunologyPathologyHuman GeneticsMast Cell ActivationMast Cell DisordersIndolent Systemic MastocytosisPrognostic CriteriaPrognostic IndicesPrognostic Marker Evaluation
To the editor: The 2008 World Health Organization (WHO) proposal recognizes 2 provisional indolent systemic mastocytosis (ISM) subvariants: smoldering systemic mastocytosis (SSM) and isolated bone marrow (BM) mastocytosis (BMM).[1][1] SSM is characterized by a high burden of mast cells (MCs; [Table
2
Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors
Ken‐Hong Lim, Ayalew Tefferi, Terra L. Lasho et al. · Blood · 2009 · 574 citations
Clinical correlates of <i>JAK2</i>V617F allele burden in essential thrombocythemia
Jaya Kittur, Ryan A. Knudson, Terra L. Lasho et al. · Cancer · 2007 · 154 citations · Full text
Medicine, Genetics, Hematology +16